» Articles » PMID: 29211035

High-Resolution Structure Analysis of Antibody V5 and U4 Conformational Epitopes on Human Papillomavirus 16

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2017 Dec 7
PMID 29211035
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Cancers attributable to human papillomavirus (HPV) place a huge burden on the health of both men and women. The current commercial vaccines are genotype specific and provide little therapeutic benefit to patients with existing HPV infections. Identifying the conformational epitopes on the virus capsid supports the development of improved recombinant vaccines to maximize long-term protection against multiple types of HPV. Fragments of antibody (Fab) digested from the neutralizing monoclonal antibodies H16.V5 (V5) and H16.U4 (U4) were bound to HPV16 capsids and the structures of the two virus-Fab complexes were solved to near atomic resolution using cryo-electron microscopy. The structures reveal virus conformational changes, the Fab-binding mode to the capsid, the residues comprising the epitope and indicate a potential interaction of U4 with the minor structural protein, L2. Competition enzyme-linked immunosorbent assay (ELISA) showed V5 outcompetes U4 when added sequentially, demonstrating a steric interference even though the footprints do not overlap. Combined with our previously reported immunological and structural results, we propose that the virus may initiate host entry through an interaction between the icosahedral five-fold vertex of the capsid and receptors on the host cell. The highly detailed epitopes identified for the two antibodies provide a framework for continuing biochemical, genetic and biophysical studies.

Citing Articles

Epitope Mapping of Exposed Tegument and Alimentary Tract Proteins Identifies Putative Antigenic Targets of the Attenuated Schistosome Vaccine.

Farias L, Vance G, Coulson P, Vitoriano-Souza J, Neto A, Wangwiwatsin A Front Immunol. 2021; 11:624613.

PMID: 33763055 PMC: 7982949. DOI: 10.3389/fimmu.2020.624613.


Structural basis for the shared neutralization mechanism of three classes of human papillomavirus type 58 antibodies with disparate modes of binding.

He M, Chi X, Zha Z, Li Y, Chen J, Huang Y J Virol. 2021; 95(7).

PMID: 33472937 PMC: 8092703. DOI: 10.1128/JVI.01587-20.


Structural characterization of a neutralizing mAb H16.001, a potent candidate for a common potency assay for various HPV16 VLPs.

Huang W, He M, Ning T, Nie J, Zhang F, Zheng Q NPJ Vaccines. 2020; 5:89.

PMID: 33042588 PMC: 7511963. DOI: 10.1038/s41541-020-00236-w.


Mapping the epitopes of Schistosoma japonicum esophageal gland proteins for incorporation into vaccine constructs.

Li X, Vance G, Cartwright J, Cao J, Wilson R, Castro-Borges W PLoS One. 2020; 15(2):e0229542.

PMID: 32107503 PMC: 7046203. DOI: 10.1371/journal.pone.0229542.

References
1.
Mejia A, Culp T, Cladel N, Balogh K, Budgeon L, Buck C . Preclinical model to test human papillomavirus virus (HPV) capsid vaccines in vivo using infectious HPV/cottontail rabbit papillomavirus chimeric papillomavirus particles. J Virol. 2006; 80(24):12393-7. PMC: 1676303. DOI: 10.1128/JVI.01583-06. View

2.
Rohou A, Grigorieff N . CTFFIND4: Fast and accurate defocus estimation from electron micrographs. J Struct Biol. 2015; 192(2):216-21. PMC: 6760662. DOI: 10.1016/j.jsb.2015.08.008. View

3.
Kilar F, Simon I, Lakatos S, Vonderviszt F, Medgyesi G, Zavodszky P . Conformation of human IgG subclasses in solution. Small-angle X-ray scattering and hydrodynamic studies. Eur J Biochem. 1985; 147(1):17-25. DOI: 10.1111/j.1432-1033.1985.tb08712.x. View

4.
Wang Z, Christensen N, Schiller J, Dillner J . A monoclonal antibody against intact human papillomavirus type 16 capsids blocks the serological reactivity of most human sera. J Gen Virol. 1997; 78 ( Pt 9):2209-15. DOI: 10.1099/0022-1317-78-9-2209. View

5.
White W, Wilson S, Woods R, Ghim S, Hewitt L, Goldman D . Characterization of a major neutralizing epitope on human papillomavirus type 16 L1. J Virol. 1999; 73(6):4882-9. PMC: 112531. DOI: 10.1128/JVI.73.6.4882-4889.1999. View